Learn bits
Health & Medicine
Pradeep Kumar

09/05/21 09:20 AM IST

Anti-COVID drug developed by DRDO

In news

An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO)

About the drug
  • The drug comes in powder form in a sachet and is taken orally by dissolving it in water.
  • It accumulates in the virus-infected cells and prevents virus growth by stopping viral synthesis and energy production.
  • Its selective accumulation in virally infected cells makes this drug unique.
  • Clinical trial results of the drug have shown that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
  • A higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID patients.
Source: PIB, The Hindu

More Related Current Affairs View All

05 May

Key objectives of caste count

'The Union Cabinet has decided that the next Census will include questions on caste to its enumeration of India’s population, for the first time in almost a century. ' T

Read More

05 May

2 new genome-edited rice varieties

'Agriculture Minister Shivraj Singh Chouhan recently released two genome-edited varieties of rice, the first achievement of its kind in the country.' These two varieties, which

Read More

05 Mar

First-ever comprehensive survey of India’s river dolphins

'Prime Minister Narendra Modi released the results of the first-ever comprehensive population estimation of riverine dolphins – Gangetic and Indus dolphins – done in In

Read More

India’s First Ai-Driven Magazine Generator

Generate Your Custom Current Affairs Magazine using our AI in just 3 steps